Publication | Closed Access

Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma

Tumor BiologyCancer Cell BiologyFirst-line Dox ResistanceUndifferentiated Spindle-cell SarcomaRadiation OncologyMedicineCell BiologyCancer ResearchRecombinant Methioninase